Abstract
Introduction Immunization coverage among children is still a major public health concern in India and other low-middle income countries. Low coverage likely risks the health of children and therefore impacts their overall growth. We therefore examined the immunization coverage rates among children aged 12-36 months in India and its states. We also explored the associated factors affecting immunization coverage among children aged 12-36 in India.
Methods We used data from 75th round of the National Sample Survey Organizations (NSSO), collected from July 2017 to June 2018. The analytical sample of children aged 12-36 months information cases was 15887. Immunization coverage rates of India and its states were calculated. We evaluated the immunization coverage rate by background characteristics in India and its states. We performed multinomial logistic regression analysis to estimate the factors associated with the immunization coverage in India.
Results About 61.95% were fully immunized, 35.62% were partially immunized and the rest 2.43% had not received any vaccine. The children aged 21-28 months (0.50; p<0.01) & 29-36 months (0.35; p<0.01), belonging to North-Eastern regions (0.60; p<0.01) were found to be significantly less likely to receive fully immunization. Likewise, urban children are (1.26; p<0.1) found to be more likely to receive fully immunization. The lowest fully immunization has been seen in Daman and Diu (1.73%) followed by Nagaland (6.93%), NCT Delhi (34.71%), and Tripura (46.33%).
Conclusions Child immunization is a key public health concern and vital challenge to be addressed. Socio-economic characteristics play a key role in immunization coverage. Therefore necessary policy measures must be taken to address the challenges of poor immunization coverage and its impact on health and wellbeing of children
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email: sadafdpsjsr{at}gmail.com
Email: mahmad{at}hs.iitr.ac.in
Email: pradhanj{at}nitrkl.ac.in
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos